0SUK47Z
Supplement Tarsometatarsal Joint, Right to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | S Lower Joints |
| Operation | U Supplement |
| Body Part | K Tarsometatarsal Joint, Right |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a lower joint that is still structurally present but needs additional support. Ligament reconstruction, such as an ACL or PCL graft in the knee, is the classic example, along with labral augmentation in the hip or cartilage grafting. Unlike replacement, the native joint stays in place; the surgery strengthens a weakened or torn portion of it.
Grafts can come from the patient's own tissue, a donor, or synthetic material, and the choice often depends on age, activity level, and the structure being reinforced. These procedures are common after athletic injuries, aiming to restore stability so the joint can withstand normal or athletic loads again.
Anatomy & Axis Detail
Tarsometatarsal Joint, Right
The right tarsometatarsal joints, commonly called the Lisfranc joint complex, connect the midfoot's cuneiforms and cuboid to the metatarsal bases and are critical to transferring push-off force during walking; when ligamentous injury or degenerative change compromises this complex, surgeons may supplement it with graft material to reinforce the joint capsule or interosseous ligaments without performing a fusion. This approach is chosen when enough native joint function remains that augmentation, rather than arthrodesis, can restore stability. Because Lisfranc injuries are notorious for subtle instability that worsens over time if undertreated, documentation should specify the exact tarsometatarsal articulation reinforced and the graft material used, since these joints are frequently injured together but coded individually.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders assign Supplement when documentation shows material was added to reinforce an existing body part rather than substitute for it, which requires confirming the native structure was not removed. Graft type, whether autograft, allograft, or synthetic, factors into the device value. A recurring mistake is coding a ligament reconstruction as Repair when a formal graft was placed, or conversely coding Supplement when the graft actually replaced a joint surface rather than reinforcing intact tissue.